Exelixis EXEL
NASDAQ EXEL
$64.39 +1.71 (+2.73%)
At close: Oct 20, 2026 · 4:00 PM EDT

Exelixis (EXEL) Deferred Taxes (2018 - 2022)

Updated

Exelixis (EXEL) recorded Deferred Taxes of -$126.24 million in FY2026, compared with $59.46 million in FY2025.

Analysis

Exelixis (EXEL) Deferred Taxes (2018 - 2022) Analysis & Trends

Starting with FY2018, Exelixis' Deferred Taxes history includes 7 years.

  • The FY2026 figure is the lowest annual Deferred Taxes in data going back to FY2018.
  • Per Business Quant data, EXEL's Deferred Taxes was $59.46 million in FY2025, $133.21 million in FY2023 (+120.7%) and $60.36 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -479.00 Mn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -195.00 Mn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -587.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -1.32 Bn
10 Exelixis 16.12 Bn 12.46 Bn 608.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 30, 2022 -60.36 Mn
Jul 1, 2022 -15.32 Mn
Apr 1, 2022 15.32 Mn
Dec 31, 2021 14.16 Mn
Oct 1, 2021 9.57 Mn
Jul 2, 2021 26.19 Mn
Apr 2, 2021 -3.39 Mn
Jan 1, 2021 -41.07 Mn
Apr 3, 2020 10.13 Mn
Sep 27, 2019 23.27 Mn
Jun 28, 2019 33.07 Mn
Dec 28, 2018 -244.11 Mn
API Access

Exelixis Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=EXEL&period=max&api_key=YOUR_API_KEY